Target intelligence / Profile preview

Human Papillomavirus Type 18 L1 Protein (None)

Target
None
Molecular classification
Viral structural protein, Capsid protein, Surface antigen
01

Overview

The Human papillomavirus type 18 (HPV18) L1 protein is the major capsid protein of HPV18, a high-risk virus associated with cervical and other anogenital cancers. The L1 protein forms the structural basis of the viral capsid and plays a critical role in virus assembly, infectivity, and immunogenicity. It is the primary target of neutralizing antibodies and the basis for prophylactic HPV vaccines.

Other names
Major capsid protein L1HPV-18 Shell ProteinHPV-18 Capsid ProteinHPV-18 Coat ProteinHPV-18 Structural ProteinHPV-18 Viral Capsid Protein L1HPV-18 Outer Capsid ProteinHPV-18 Shell Component L1HPV-18 Capsomer Protein L1HPV Surface Antigen L1
02

Mechanism of action

L1 protein-based vaccines induce neutralizing antibodies that prevent HPV infection by blocking viral entry into host cells.

03

Biological functions

Virion assemblyHost cell attachmentImmune recognitionNeutralization targetVaccine antigen
04

Disease associations

Cervical cancerAnogenital cancersHPV18 infection
05

Interacting drugs

HPV vaccines (e.g., Gardasil, Cervarix)

Beyond the preview

Go deeper on Human Papillomavirus Type 18 L1 Protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Papillomavirus Type 18 L1 Protein (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call